🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 2-part study of mavorixafor in participants diagnosed with chroni...
Status
Completed
Location
USF Health Department of Pediatrics
Start Date
2021-10-16
Trial ID
NCT04154488
Treatments Being Tested
The primary objective of the study is to establish a pharmacologically acti...
Status
Completed
Location
Colorado Blood Cancer Institute
Start Date
2020-04-30
Trial ID
NCT04274738
Treatments Being Tested
This is a Phase 2 study with an initial 24-week Treatment Period and an Ext...
Status
Completed
Location
University of Washington Medical Center
Start Date
2016-12
Trial ID
NCT03005327
Treatments Being Tested
New treatment options are critical for treatment-experienced HIV infected p...
Status
Completed
Location
Alabama Therapeutics CRS
Start Date
2004-11
Trial ID
NCT00089466
Treatments Being Tested
The main purpose of this study is to evaluate drug-drug interaction (DDI) o...
Status
Completed
Location
Parexel International LLC
Start Date
2025-02-18
Trial ID
NCT06914869
Treatments Being Tested
The goals of this protocol are 1) to investigate the safety and tolerabilit...
Status
Completed
Location
Clinical Site
Start Date
2016-09-15
Trial ID
NCT02823405
Treatments Being Tested
This study has a double-blind, Randomized Placebo-Controlled Period and an ...
Status
Completed
Location
University of California San Diego Health/Rady Children's Hospital
Start Date
2019-10-24
Trial ID
NCT03995108
Treatments Being Tested
The purpose of this study is to measure the effect of HI on the PK, safety,...
Status
Completed
Location
Catalina Research Institute, LLC
Start Date
2025-02-28
Trial ID
NCT06858696
Treatments Being Tested
The purpose of this study is to determine if the combination of X4P-001 plu...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-07
Trial ID
NCT02923531
Objectives Phase 1b Primary Objectives: To evaluate the safety and tolera...
Status
Unknown
Location
Shang hai Tumor Hospital
Start Date
2021-07-21
Trial ID
NCT05103917
Treatments Being Tested